跳至主要内容
临床试验/NCT01149876
NCT01149876已完成4 期

A Single Blind, Placebo Controlled Trial to Evaluate Effects of a Study Medication, a Nu Skin Lightening Product With and Without Iontophoresis vs Tretinoin Cream vs Vehicle Control for Facial Hyperpigmentation

Massachusetts General Hospital1 个研究点 分布在 1 个国家目标入组 80 人开始时间: 2010年6月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
80
试验地点
1
主要终点
Change in Hyperpigmentation of the Face

研究概览

简要总结

The purpose of this study is to determine whether a topical Nu Skin product with or without a galvanic spa device improves brown spots on the face. The Nu Skin product will be compared to an over the counter moisturizer and tretinoin cream.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Investigator)

入排标准

年龄范围
25 Years 至 55 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Able to understand and sign informed consent.
  • Able to complete study and comply with study procedures.
  • Caucasian female ages 25-
  • Presence of photodamage and lentigines of II-III on the Glogau Photoaging
  • Must be willing to avoid laser and light treatments, treatments with filler, chemical peels, microdermabrasion, Botox or any other cosmetic treatment to the face during the duration of the study.
  • Must be willing to avoid changing topical moisturizers and cosmetics during the study.
  • Able to stop any alpha or beta hydroxy acids, topical retinol or retinoid derivatives, topical antioxidants, or any topical product that may interfere with the study 2 weeks prior to the study.

排除标准

  • Cosmetic treatment of face, such as laser or light treatment, filler, Botox, microdermabrasion, or chemical peels 6 months prior to study or during study.
  • Current smoker.
  • Pregnant, nursing, or planning to become pregnant during study.
  • Currently taking drugs including oral retinoids or any other medication with a known clinically significant drug interaction with topical tretinoin.
  • Known hypersensitivity to retinoids. History of severe retinoid dermatitis.
  • History of substance abuse, mental dysfunction, or other factors limiting ability to cooperate with study.
  • Concurrent participation in another clinical study or participation 30 days prior to enrollment that includes exposure to an investigational drug that would interfere with this study.
  • Any disease or condition which would interfere with study participation or unduly increase risk.
  • Presence of an electrically sensitive support system such as a pacemaker.
  • Known history of epilepsy.
  • Presence of metal implants or metal braces on teeth.

研究组 & 干预措施

Nu Skin product with galvanic spa system

Experimental

干预措施: Cosmetic instrument (Other)

Nu Skin Product

Experimental

干预措施: Nu Skin Product (Other)

Nu Skin product with galvanic spa system

Experimental

干预措施: Nu Skin Product (Other)

Tretinoin cream 0.05

Active Comparator

干预措施: Tretinoin cream 0.05 (Drug)

over the counter moisturizer

Placebo Comparator

干预措施: CeraVe moisturizer (Other)

结局指标

主要结局

Change in Hyperpigmentation of the Face

时间窗: baseline to 16 weeks

Primary outcome measure will be change in hyperpigmentation of baseline compared to week 16. Hyperpigmentation will be measured clinically using a 0-6 scale where 0 is no hyperpigmentation and 6 is very severe hyperpigmentation.

次要结局

  • Change in Rhytides(baseline to week 16)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Molly A. Wanner, MD

Assistant Physician, Dermatology

Massachusetts General Hospital

研究点 (1)

Loading locations...

相似试验